Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $5.51, for a total transaction of $339,217.64. Following the sale, the insider now directly owns 1,453,948 shares of the company's stock, valued at approximately $8,011,253.48. The trade was a 4.06 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.
Aveanna Healthcare Stock Down 0.9 %
Shares of Aveanna Healthcare stock opened at $5.46 on Friday. Aveanna Healthcare Holdings Inc. has a 52 week low of $2.11 and a 52 week high of $6.19. The company has a 50 day moving average price of $4.63 and a 200 day moving average price of $4.96. The firm has a market capitalization of $1.06 billion, a P/E ratio of -16.06 and a beta of 2.25.
Hedge Funds Weigh In On Aveanna Healthcare
Several hedge funds and other institutional investors have recently bought and sold shares of AVAH. KLP Kapitalforvaltning AS acquired a new position in Aveanna Healthcare in the 4th quarter worth approximately $35,000. BNP Paribas Financial Markets acquired a new position in Aveanna Healthcare in the 4th quarter worth approximately $35,000. Tower Research Capital LLC TRC increased its holdings in Aveanna Healthcare by 662.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after buying an additional 6,854 shares during the period. Catalyst Funds Management Pty Ltd increased its holdings in Aveanna Healthcare by 321.4% in the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock worth $54,000 after buying an additional 9,000 shares during the period. Finally, Sagespring Wealth Partners LLC acquired a new position in Aveanna Healthcare in the 4th quarter worth approximately $57,000. Institutional investors and hedge funds own 87.96% of the company's stock.
Analyst Ratings Changes
AVAH has been the subject of several analyst reports. Truist Financial decreased their price target on shares of Aveanna Healthcare from $6.00 to $5.25 and set a "hold" rating for the company in a research report on Monday, January 6th. UBS Group increased their price objective on shares of Aveanna Healthcare from $3.20 to $4.50 and gave the company a "sell" rating in a research report on Friday, March 14th.
Check Out Our Latest Research Report on AVAH
About Aveanna Healthcare
(
Get Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
